Active (not recruiting) Phase 1 2025-524106-14-00

A study in healthy people to test how vicadrostat affects the heart

Phase 1 – testing safety in a small group of people

Conditions: Healthy volunteer trial

Sponsor: Boehringer Ingelheim International GmbH

trial.available_in:

БГ

Overview

Trial status: Authorised

Who can participate

Age group: 18-64 years Gender: Female, Male Target enrollment: 45 participants

Germany (1)

Status

Active (not recruiting)

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Maximum age

64 Years

Healthy volunteers

Start date

20.03.2026

Registry ID

2025-524106-14-00

Source

euclinicaltrials.eu

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.